Cited by 692Acute Myeloid Leukemia ResearchGenomics and Chromatin DynamicsChromatin Remodeling and Cancer

The DOI matches its Crossref record; 50 of the 51 references it cites were found in a registry or an index.

A Single Oncogenic Enhancer Rearrangement Causes Concomitant EVI1 and GATA2 Deregulation in Leukemia

Open access

Gröschel, Stefan, Sanders, Mathijs A., Hoogenboezem, Remco, de Wit, Elzo, Bouwman, Britta A.M., Erpelinck, Claudia, van der Velden, Vincent H.J., Havermans, Marije, Avellino, Roberto, van Lom, Kirsten, Rombouts, Elwin J., van Duin, Mark, Döhner, Konstanze, Beverloo, H. Berna, Bradner, James E., Döhner, Hartmut, Löwenberg, Bob, Valk, Peter J.M., Bindels, Eric M.J., de Laat, Wouter, Delwel, Ruud·2014·Cell

DOI 10.1016/j.cell.2014.02.019

Open this paper in CoChat — free account Open PDF

Abstract

Chromosomal rearrangements without gene fusions have been implicated in leukemogenesis by causing deregulation of proto-oncogenes via relocation of cryptic regulatory DNA elements. AML with inv(3)/t(3;3) is associated with aberrant expression of the stem-cell regulator EVI1. Applying functional genomics and genome-engineering, we demonstrate that both 3q rearrangements reposition a distal GATA2 enhancer to ectopically activate EVI1 and simultaneously confer GATA2 functional haploinsufficiency, previously identified as the cause of sporadic familial AML/MDS and MonoMac/Emberger syndromes. Genomic excision of the ectopic enhancer restored EVI1 silencing and led to growth inhibition and differentiation of AML cells, which could be replicated by pharmacologic BET inhibition. Our data show that structural rearrangements involving the chromosomal repositioning of a single enhancer can cause deregulation of two unrelated distal genes, with cancer as the outcome.

Integrity signals

Registry

Crossref · 10.1016/j.cell.2014.02.019

Cites

50 of 50 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

The Sequence Alignment/Map format and SAMtools
Li, H., Handsaker, B., Wysoker, A., Fennell, T., Ruan, J., Homer, N., Marth, G., Abecasis, G., Durbin, R., & 1000 Genome Project Data Processing Subgroup (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp352 · Cited by 62,041
Fast and accurate short read alignment with Burrows-Wheeler transform
Li, H., & Durbin, R. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp324 · Cited by 58,607
Model-based Analysis of ChIP-Seq (MACS)
Zhang, Y., Liu, T., Meyer, C. A., Eeckhoute, J., Johnson, D. S., Bernstein, B. E., Nusbaum, C., Myers, R. M., Brown, M., Li, W., et al. (2008) · Genome Biology · doi:10.1186/gb-2008-9-9-r137 · Cited by 18,386
Integrative genomics viewer
Robinson, J. T., Thorvaldsdóttir, H., Winckler, W., Guttman, M., Lander, E. S., Getz, G., & Mesirov, J. P. (2011) · Nature Biotechnology · doi:10.1038/nbt.1754 · Cited by 15,390
Multiplex Genome Engineering Using CRISPR/Cas Systems
Cong, L., Ran, F. A., Cox, D., Lin, S., Barretto, R., Habib, N., Hsu, P. D., Wu, X., Jiang, W., Marraffini, L. A., et al. (2013) · Science · doi:10.1126/science.1231143 · Cited by 15,339
TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions.
Kim, D., Pertea, G., Trapnell, C., Pimentel, H., Kelley, R., & Salzberg, S. L. (2013) · Genome Biology · doi:10.1186/gb-2013-14-4-r36 · Cited by 12,668
Velvet: Algorithms for de novo short read assembly using de Bruijn graphsPreprint
Zerbino, D. R., & Birney, E. (2008) · Genome Research · doi:10.1101/gr.074492.107 · Cited by 9,587
RNA-Guided Human Genome Engineering via Cas9
Mali, P., Yang, L., Esvelt, K. M., Aach, J., Guell, M., DiCarlo, J. E., Norville, J. E., & Church, G. M. (2013) · Science · doi:10.1126/science.1232033 · Cited by 9,210
Topological domains in mammalian genomes identified by analysis of chromatin interactions
Dixon, J. R., Selvaraj, S., Yue, F., Kim, A., Li, Y., Shen, Y., Hu, M., Liu, J. S., & Ren, B. (2012) · Nature · doi:10.1038/nature11082 · Cited by 6,829
Master Transcription Factors and Mediator Establish Super-Enhancers at Key Cell Identity Genes
Whyte, W. A., Orlando, D. A., Hnisz, D., Abraham, B. J., Lin, C. Y., Kagey, M. H., Rahl, P. B., Lee, T. I., & Young, R. A. (2013) · Cell · doi:10.1016/j.cell.2013.03.035 · Cited by 4,143

Show all 51 references

Sorted by citations

Items 201–300 of 692

The Stochastic Genome and Its Role in Gene ExpressionPreprint
Bohrer, C. H., & Larson, D. R. (2021) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a040386 · Cited by 43
Novel insights into chromosomal conformations in cancer
Jia, R., Chai, P., Zhang, H., & Fan, X. (2017) · Molecular Cancer · doi:10.1186/s12943-017-0741-5 · Cited by 45
Constructing and deconstructing GATA2-regulated cell fate programs to establish developmental trajectories
Johnson, K. D., Conn, D. J., Shishkova, E., Katsumura, K. R., Liu, P., Shen, S., Ranheim, E. A., Kraus, S. G., Wang, W., Calvo, K. R., et al. (2020) · The Journal of Experimental Medicine · doi:10.1084/jem.20191526 · Cited by 41
Hierarchical chromatin organization detected by TADpole
Soler-Vila, P., Cuscó, P., Farabella, I., Stefano, M. D., & Martı́-Renom, M. A. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa087 · Cited by 39
Functional and molecular characterization of mouse Gata2-independent hematopoietic progenitors
Kaimakis, P., de Pater, E., Eich, C., Kartalaei, P. S., Kauts, M., Vink, C. S., van der Linden, R., Jaegle, M., Yokomizo, T., Meijer, D., et al. (2016) · Blood · doi:10.1182/blood-2015-10-673749 · Cited by 37
Human dendritic cell immunodeficiencies
Bigley, V., Cytlak, U., & Collin, M. P. (2018) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2018.02.020 · Cited by 41
Enhancer DNA methylation in acute myeloid leukemia and myelodysplastic syndromes
Benetatos, L., & Vartholomatos, G. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2783-2 · Cited by 42
Transcriptional dysregulation by aberrant enhancer activation and rewiring in cancer
Okabe, A., & Kaneda, A. (2021) · Cancer Science · doi:10.1111/cas.14884 · Cited by 41
EVI1 drives leukemogenesis through aberrant ERG activation
Schmoellerl, J., Barbosa, I. A. M., Minnich, M., Andersch, F., Smeenk, L., Havermans, M., Eder, T., Neumann, T., Jude, J., Fellner, M., et al. (2022) · Blood · doi:10.1182/blood.2022016592 · Cited by 41
Self-citation
Molecular basis of crosstalk between oncogenic Ras and the master regulator of hematopoiesis GATA‐2
Katsumura, K. R., Yang, C., Boyer, M. E., Li, L., & Bresnick, E. H. (2014) · EMBO Reports · doi:10.15252/embr.201438808 · Cited by 38
Epigenetic Determinants of Erythropoiesis: Role of the Histone Methyltransferase SetD8 in Promoting Erythroid Cell Maturation and Survival
DeVilbiss, A., Sanalkumar, R., Hall, B. D. R., Katsumura, K. R., de Andrade, I. F., & Bresnick, E. H. (2015) · Molecular and Cellular Biology · doi:10.1128/mcb.01422-14 · Cited by 37
An oncogenic enhancer encodes selective selenium dependency in AML
Eagle, K., Jiang, Y., Shi, X. E., Li, M., Obholzer, N. D., Hu, T., Perez, M. W., Koren, J. V., Kitano, A., Yi, J. S., et al. (2022) · Cell stem cell · doi:10.1016/j.stem.2022.01.003 · Cited by 40
An epigenetic perspective on tumorigenesis: Loss of cell identity, enhancer switching, and NamiRNA network
Liang, Y. J., Xu, P., Zou, Q., Luo, H., & Yu, W. (2018) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2018.09.004 · Cited by 37
Super-enhancers: A new frontier for glioma treatment
Cheng, M., Zhang, Z. W., Ji, X., Xu, Y., Bian, E., & Zhao, B. (2020) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2020.188353 · Cited by 35
Pervasive structural heterogeneity rewires glioblastoma chromosomes to sustain patient-specific transcriptional programs
Xie, T., Danieli‐Mackay, A., Buccarelli, M., Barbieri, M., Papadionysiou, I., D’Alessandris, Q. G., Robens, C., Übelmesser, N., Vinchure, O. S., Lauretti, L., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-48053-2 · Cited by 36
HEXIM1 induction is mechanistically involved in mediating anti-AML activity of BET protein bromodomain antagonist
Devaraj, S. G. T., Fiskus, W. C., Shah, B. N., Qi, J., Sun, B., Iyer, S. P., Sharma, S., Bradner, J. E., & Bhalla, K. N. (2015) · Leukemia · doi:10.1038/leu.2015.142 · Cited by 36
Self-citation
Regulatory elements in molecular networks
Doane, A. S., & Elemento, O. (2017) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.1374 · Cited by 40
Effective normalization for copy number variation in Hi-C data
Servant, N., Varoquaux, N., Heard, E., Barillot, E., & Vert, J.-P. (2017) · BMC Bioinformatics · doi:10.1186/s12859-018-2256-5 · Cited by 34
Revisiting 3D chromatin architecture in cancer development and progression
Feng, Y., & Pauklin, S. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa747 · Cited by 36
EVI1 in Leukemia and Solid Tumors
Liang, B., & Wang, J. (2020) · Cancers · doi:10.3390/cancers12092667 · Cited by 36
A dose escalation study of RO6870810/TEN-10 in patients with acute myeloid leukemia and myelodysplastic syndrome
Roboz, G. J., Desai, P. M., Lee, S., Ritchie, E. K., Winer, E. S., DeMario, M., Brennan, B. J., Nüesch, E., Chesné, E., Brennan, L., et al. (2021) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428194.2021.1881509 · Cited by 36
KLF7 regulates super-enhancer-driven IGF2BP2 overexpression to promote the progression of head and neck squamous cell carcinoma
Cai, H., Liang, J., Jiang, Y., Wang, Z., Li, H., Wang, W., Wang, C., & Hou, J. (2024) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-024-02996-y · Cited by 35
Enhancer reprogramming in tumor progression: a new route towards cancer cell plasticity
Fagnocchi, L., Poli, V., & Zippo, A. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2820-1 · Cited by 38
A unifying model for extrachromosomal circular DNA load in eukaryotic cells
Arrey, G., Keating, S. T., & Regenberg, B. (2022) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2022.03.002 · Cited by 37
The Many Faces of Gene Regulation in Cancer: A Computational Oncogenomics Outlook
Lemus, E. H., Reyes-Gopar, H., Enríquez, J. E., & Ochoa, S. (2019) · Genes · doi:10.3390/genes10110865 · Cited by 33
Genomic profiling of HIV-1 integration in microglia cells links viral integration to the topologically associated domains
Rheinberger, M., Costa, A. L., Kampmann, M., Glavaš, D., Shytaj, I. L., Sreeram, S., Penzo, C., Tibroni, N., García‐Mesa, Y., Leskov, K., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112110 · Cited by 33
Structural variants in the 3D genome as drivers of disease
Sreenivasan, V. K. A., Yumiceba, V., & Spielmann, M. (2025) · Nature Reviews Genetics · doi:10.1038/s41576-025-00862-x · Cited by 45
Transcriptional network control of normal and leukaemic haematopoiesis
Sive, J. I., & Göttgens, B. (2014) · Experimental Cell Research · doi:10.1016/j.yexcr.2014.06.021 · Cited by 35
Insights about genome function from spatial organization of the genome
Roy, S. S., Mukherjee, A. K., & Chowdhury, S. (2018) · Human Genomics · doi:10.1186/s40246-018-0140-z · Cited by 32
Transcriptional networks in acute myeloid leukemia
Thoms, J. A. I., Beck, D., & Pimanda, J. E. (2019) · Genes Chromosomes and Cancer · doi:10.1002/gcc.22794 · Cited by 33
RUNX1-ETO Depletion in t(8;21) AML Leads to C/EBPα- and AP-1-Mediated Alterations in Enhancer-Promoter Interaction
Ptasinska, A., Pickin, A., Assi, S. A., Chin, P. S., Ames, L., Avellino, R., Gröschel, S., Delwel, R., Cockerill, P. N., Osborne, C. S., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.08.040 · Cited by 37
Self-citation
Topologically Associating Domains in Chromosome Architecture and Gene Regulatory Landscapes during Development, Disease, and EvolutionPreprint
Galupa, R., & Heard, É. (2017) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2017.82.035030 · Cited by 30
Mapping oncogenic protein interactions for precision medicine
Tabar, M. S., Francis, H., Yeo, D., Bailey, C. G., & Rasko, J. E. J. (2022) · International Journal of Cancer · doi:10.1002/ijc.33954 · Cited by 30
3D genomic analysis reveals novel enhancer-hijacking caused by complex structural alterations that drive oncogene overexpression
Mortenson, K. L., Dawes, C., Wilson, E. R., Patchen, N. E., Johnson, H. E., Gertz, J., Bailey, S. D., Yang, J., Varley, K. E., & Zhang, X. (2024) · Nature Communications · doi:10.1038/s41467-024-50387-w · Cited by 35
3q26/ EVI1 rearrangements in myeloid hemopathies: a cytogenetic review
Braekeleer, M. D., Bris, M. L., Braekeleer, E. D., Basinko, A., Morel, F., & Douet‐Guilbert, N. (2015) · Future Oncology · doi:10.2217/fon.15.64 · Cited by 32
PRDM16s transforms megakaryocyte-erythroid progenitors into myeloid leukemia–initiating cells
Hu, T., Morita, K., Hill, M. C., Jiang, Y., Kitano, A., Saito, Y., Wang, F., Mao, X., Hoegenauer, K. A., Morishita, K., et al. (2019) · Blood · doi:10.1182/blood.2018888255 · Cited by 32
Blood disease–causing and –suppressing transcriptional enhancers: general principles and GATA2 mechanisms
Bresnick, E. H., & Johnson, K. D. (2019) · Blood Advances · doi:10.1182/bloodadvances.2019000378 · Cited by 32
Super-enhancers and novel therapeutic targets in colorectal cancer
Liu, Q., Guo, L., Lou, Z., Xiang, X., & Shao, J. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-04673-4 · Cited by 31
Oct4-Mediated Inhibition of Lsd1 Activity Promotes the Active and Primed State of Pluripotency Enhancers
AlAbdi, L., Saha, D., He, M., Dar, M. S., Utturkar, S. M., Sudyanti, P. A., McCune, S., Spears, B. H., Breedlove, J. A., Lanman, N. A., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2019.11.040 · Cited by 29
CTCF-mediated genome organization and leukemogenesis
Qiu, Y., & Huang, S. (2020) · Leukemia · doi:10.1038/s41375-020-0906-x · Cited by 32
Prevalence of germline GATA2 and SAMD9/9L variants in paediatric haematological disorders with monosomy 7
Yoshida, M., Tanase‐Nakao, K., Shima, H., Shirai, R., Yoshida, K., Osumi, T., Deguchi, T., Mori, M., Arakawa, Y., Takagi, M., et al. (2020) · British Journal of Haematology · doi:10.1111/bjh.17006 · Cited by 31
SuperTAD: robust detection of hierarchical topologically associated domains with optimized structural information
Zhang, Y., Wang, M., & Li, S. C. (2021) · Genome biology · doi:10.1186/s13059-020-02234-6 · Cited by 29
Identification of therapeutic targets of the hijacked super-enhancer complex in EVI1-rearranged leukemia
Kiehlmeier, S., Rafiee, M., Bakr, A., Mika, J., Kruse, S., Müller, J., Schweiggert, S., Herrmann, C., Sigismondo, G., Schmezer, P., et al. (2021) · Leukemia · doi:10.1038/s41375-021-01235-z · Cited by 34
Self-citation
Regulation and Dysregulation of Chromosome Structure in Cancer
Hnisz, D., Schuijers, J., Li, C. H., & Young, R. A. (2017) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-030617-050134 · Cited by 31
Perturbing Enhancer Activity in Cancer Therapy
Hamdan, F. H., & Johnsen, S. A. (2019) · Cancers · doi:10.3390/cancers11050634 · Cited by 31
An epigenetic perspective on tumorigenesis: Loss of cell identity, enhancer switching, and NamiRNA network
Liang, Y. J., Xu, P., Zou, Q., Luo, H., & Yu, W. (2018) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2018.09.001 · Cited by 32
Allele-specific expression of GATA2 due to epigenetic dysregulation in CEBPA double-mutant AML
Mulet‐Lazaro, R., van Herk, S., Erpelinck-Verschueren, C. A. J., Bindels, E. M., Sanders, M. A., Vermeulen, C., Renkens, I., Valk, P. J. M., Melnick, A. M., de Ridder, J., et al. (2021) · Blood · doi:10.1182/blood.2020009244 · Cited by 32
Self-citation
Novel Function of a Transcription Factor WT1 in Regulating Decidualization in Human Endometrial Stromal Cells and Its Molecular Mechanism
Tamura, I., Shirafuta, Y., Jozaki, K., Kajimura, T., Shinagawa, M., Maekawa, R., Taketani, T., Asada, H., Sato, S., Tamura, H., et al. (2017) · Endocrinology · doi:10.1210/en.2017-00478 · Cited by 30
Hijacked enhancer–promoter and silencer–promoter loops in cancer
Wang, X., & Yue, F. (2024) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2024.102199 · Cited by 32
Chromatin Interactions and Regulatory Elements in Cancer: From Bench to Bedside
See, Y. X., Wang, B. Z., & Fullwood, M. J. (2018) · Trends in Genetics · doi:10.1016/j.tig.2018.11.007 · Cited by 29
LSD1-mediated repression of GFI1 super-enhancer plays an essential role in erythroleukemia
Tatsumi, G., Kawahara, M., Yamamoto, R., Hishizawa, M., Kito, K., Suzuki, T., Takaori‐Kondo, A., & Andoh, A. (2019) · Leukemia · doi:10.1038/s41375-019-0614-6 · Cited by 30
Targeting Oncogenic Super Enhancers in MYC-Dependent AML Using a Small Molecule Activator of NR4A Nuclear Receptors
Call, S. G., Duren, R. P., Panigrahi, A. K., Nguyen, L., Freire, P. R., Grimm, S. L., Coarfa, C., & Conneely, O. M. (2020) · Scientific Reports · doi:10.1038/s41598-020-59469-3 · Cited by 31
Determinants and role of chromatin organization in acute leukemia
Fang, C., Rao, S., Crispino, J. D., & Ntziachristos, P. (2020) · Leukemia · doi:10.1038/s41375-020-0981-z · Cited by 30
Challenging conventional karyotyping by next-generation karyotyping in 281 intensively treated patients with AML
Mareschal, S., Palau, A., Lindberg, J., Ruminy, P., Nilsson, C. C., Bengtzén, S., Engvall, M., Eriksson, A., Neddermeyer, A., Marchand, V., et al. (2021) · Blood Advances · doi:10.1182/bloodadvances.2020002517 · Cited by 29
Tumor suppressor function of Gata2 in acute promyelocytic leukemia
Katerndahl, C. D. S., Rogers, O. R. S., Day, R. B., Cai, M., Rooney, T. P., Helton, N., Hoock, M., Ramakrishnan, S. M., Srivatsan, S. N., Wartman, L. D., et al. (2021) · Blood · doi:10.1182/blood.2021011758 · Cited by 29
Histone H3K36me2 demethylase KDM2A promotes bladder cancer progression through epigenetically silencing RARRES3
Lu, B., Wei, J., Zhou, H., Chen, J., Li, Y., Ye, L., Zhao, W., & Wu, S. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-04983-7 · Cited by 29
Enhancer Coamplification and Hijacking Promote Oncogene Expression in Liposarcoma
Liu, T., Wang, J., Yang, H., Jin, Q., Wang, X., Fu, Y., Luan, Y., Wang, Q., Youngblood, M. W., Lu, X., et al. (2023) · Cancer Research · doi:10.1158/0008-5472.can-22-1858 · Cited by 30
Panobinostat for the treatment of acute myelogenous leukemia
Morabito, F., Voso, M. T., Hohaus, S., Gentile, M., Vigna, E., Recchia, A. G., Iovino, L., Benedetti, E., Lo‐Coco, F., & Galimberti, S. (2016) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2016.1216971 · Cited by 30
Enhancer-gene rewiring in the pathogenesis of Quebec Platelet Disorder
Liang, M., Soomro, A., Tasneem, S., Abatti, L. E., Alizada, A., Yuan, X., Uusküla-Reimand, L., Antounians, L., Alvi, S. A., Paterson, A. D., et al. (2020) · Blood · doi:10.1182/blood.2020005394 · Cited by 30
Deciphering the complexities of MECOM rearrangement-driven chromosomal aberrations
Tang, Z., Tang, G., Hu, S., Patel, K. P., Yin, C. C., Wang, W., Lin, P., Törüner, G., Ok, C. Y., Gu, J., et al. (2019) · Cancer Genetics · doi:10.1016/j.cancergen.2019.03.002 · Cited by 28
Combined inhibition of XIAP and BCL2 drives maximal therapeutic efficacy in genetically diverse aggressive acute myeloid leukemia
Hashimoto, M., Saito, Y., Nakagawa, R., Ogahara, I., Takagi, S., Takata, S., Amitani, H., Endo, M., Yuki, H., Ramilowski, J. A., et al. (2021) · Nature Cancer · doi:10.1038/s43018-021-00177-w · Cited by 29
The dynamics of three-dimensional chromatin organization and phase separation in cell fate transitions and diseases
Ling, X., Liu, X., Jiang, S., Fan, L., & Ding, J. (2022) · Cell Regeneration · doi:10.1186/s13619-022-00145-4 · Cited by 29
Allogeneic hematopoietic cell transplantation in patients with GATA2 deficiency—a case report and comprehensive review of the literature
Simonis, A., Fux, M., Nair, G., Mueller, N. J., Haralambieva, E., Pabst, T., Schmid, J. P., Schmidt, A., Schanz, U., Manz, M. G., et al. (2018) · Annals of Hematology · doi:10.1007/s00277-018-3388-4 · Cited by 27
Integrative analysis of epigenetics data identifies gene-specific regulatory elements
Schmidt, F., Marx, A., Baumgarten, N., Hebel, M., Wegner, M., Kaulich, M., Leisegang, M. S., Brandes, R. P., Göke, J., Vreeken, J., et al. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab798 · Cited by 25
Structural variation cooperates with permissive chromatin to control enhancer hijacking–mediated oncogenic transcription
Botten, G., Zhang, Y., Dudnyk, K., Kim, Y., Liu, X., Sanders, J. T., Imanci, A., Droin, N., Cao, H., Kaphle, P., et al. (2022) · Blood · doi:10.1182/blood.2022017555 · Cited by 29
Etiology of super-enhancer reprogramming and activation in cancer
Zhou, R. W., & Parsons, R. E. (2023) · Epigenetics & Chromatin · doi:10.1186/s13072-023-00502-w · Cited by 31
DNA Methylation of Enhancer Elements in Myeloid Neoplasms: Think Outside the Promoters?
Ordóñez, R., Martínez‐Calle, N., Agirre, X., & Prósper, F. (2019) · Cancers · doi:10.3390/cancers11101424 · Cited by 26
Targeting complexes of super‑enhancers is a promising strategy for cancer therapy (Review)
Zheng, C., Liu, M., & Fan, H. (2020) · Oncology Letters · doi:10.3892/ol.2020.11855 · Cited by 27
Tissue Regeneration Enhancer Elements: A Way to Unlock Endogenous Healing Power
Yang, K., & Kang, J. (2018) · Developmental Dynamics · doi:10.1002/dvdy.24676 · Cited by 26
Panoramic view of common fusion genes in a large cohort of Chinese de novo acute myeloid leukemia patients
Chen, X., Wang, F., Zhang, Y., Wang, M., Tian, W., Teng, W., Ma, X., Guo, L., Fang, J., Zhang, Y., et al. (2018) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428194.2018.1516876 · Cited by 26
The Role of Somatic Mutations in Acute Myeloid Leukemia PathogenesisPreprint
Kishtagari, A., & Levine, R. L. (2020) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a034975 · Cited by 26
EVI1 and GATA2 misexpression induced by inv(3)(q21q26) contribute to megakaryocyte-lineage skewing and leukemogenesis
Yamaoka, A., Suzuki, M., Katayama, S., Orihara, D., Engel, J. D., & Yamamoto, M. P. (2020) · Blood Advances · doi:10.1182/bloodadvances.2019000978 · Cited by 25
Role of Enhancers in Development and Diseases
Maurya, S. S. (2021) · Epigenomes · doi:10.3390/epigenomes5040021 · Cited by 26
Phase I Results of Bromodomain and Extra-Terminal Inhibitor PLX51107 in Combination with Azacitidine in Patients with Relapsed/Refractory Myeloid Malignancies
Senapati, J., Fiskus, W. C., Daver, N. G., Wilson, N. R., Ravandi, F., Garcia‐Manero, G., Kadia, T. M., Dinardo, C. D., Jabbour, E. J., Burger, J. A., et al. (2023) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-23-1429 · Cited by 25
Altered TERT promoter and other genomic regulatory elements: occurrence and impact
Heidenreich, B., & Kumar, R. (2017) · International Journal of Cancer · doi:10.1002/ijc.30735 · Cited by 26
Mechanisms Underlying the Selection and Function of Macrophage-Specific EnhancersPreprint
Link, V. M., Gosselin, D., & Glass, C. K. (2015) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2015.80.027367 · Cited by 25
AlloHSCT for inv(3)(q21;q26)/t(3;3)(q21;q26) AML: a report from the acute leukemia working party of the European society for blood and marrow transplantation
Hałaburda, K., Labopin, M., Houhou, M., Niederwieser, D. W., Finke, J., Volin, L., Maertens, J. A., Cornelissen, J. J., Milpied, N. J., Stuhler, G., et al. (2018) · Bone Marrow Transplantation · doi:10.1038/s41409-018-0165-x · Cited by 24
Redefining the biological basis of lineage-ambiguous leukemia through genomics: BCL11B deregulation in acute leukemias of ambiguous lineage
Montefiori, L. E., & Mullighan, C. G. (2021) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2021.101329 · Cited by 25
Selective Inhibitors of Histone Deacetylases 1 and 2 Synergize with Azacitidine in Acute Myeloid Leukemia
Min, C., Moore, N., Shearstone, J. R., Quayle, S. N., Huang, P., van Duzer, J. H., Jarpe, M. B., Jones, S. S., & Yang, M. (2017) · PLoS ONE · doi:10.1371/journal.pone.0169128 · Cited by 24
Diverse noncoding mutations contribute to deregulation of cis-regulatory landscape in pediatric cancers
He, B., Gao, P., Ding, Y., Chen, C.-H., Chen, G., Chen, C., Kim, H., Tasian, S. K., Hunger, S. P., & Tan, K. (2020) · Science Advances · doi:10.1126/sciadv.aba3064 · Cited by 25
Acute myeloid leukemia with inv(3)(q21.3q26.2)/t(3;3)(q21.3;q26.2): Study of 61 patients treated with intensive protocols
Sitges, M., Boluda, B., Garrido, A., Morgades, M., Granada, I., Barragán, E., Arnán, M., Serrano, J., Tormo, M., Bergua, J., et al. (2020) · European Journal Of Haematology · doi:10.1111/ejh.13417 · Cited by 23
From DNA human sequence to the chromatin higher order organisation and its biological meaning: Using biomolecular interaction networks to understand the influence of structural variation on spatial genome organisation and its functional effect
Chiliński, M., Sengupta, K., & Plewczyński, D. (2021) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2021.08.007 · Cited by 23
Aberrant EVI1 splicing contributes to EVI1-rearranged leukemia
Tanaka, A., Nakano, T. A., Nomura, M., Yamazaki, H., Bewersdorf, J. P., Mulet‐Lazaro, R., Hogg, S. J., Liu, B., Penson, A., Yokoyama, A., et al. (2022) · Blood · doi:10.1182/blood.2021015325 · Cited by 25
Self-citation
Superenhancers as master gene regulators and novel therapeutic targets in brain tumors
Zhuang, H.-H., Qu, Q., Teng, X.-Q., Dai, Y.-H., & Qu, J. (2023) · Experimental & Molecular Medicine · doi:10.1038/s12276-023-00934-0 · Cited by 24
Characteristics and clinical outcomes of patients with acute myeloid leukemia with inv(3)(q21q26.2) or t(3;3)(q21;q26.2)
Richard‐Carpentier, G., Rausch, C. R., Sasaki, K., Hammond, D. E., Morita, K., Takahashi, K., Tang, G., Kanagal‐Shamanna, R., Bhalla, K. N., Dinardo, C. D., et al. (2023) · Haematologica · doi:10.3324/haematol.2022.282030 · Cited by 23
Role of the pioneer transcription factor GATA2 in health and disease
Aktar, A., & Heit, B. (2023) · Journal of Molecular Medicine · doi:10.1007/s00109-023-02359-8 · Cited by 23
Functional annotation of HOT regions in the human genome: implications for human disease and cancer
Li, H., Chen, H., Liu, F., Ren, C., Wang, S., Bo, X., & Shu, W. (2015) · Scientific Reports · doi:10.1038/srep11633 · Cited by 23
Unexpected redundancy of Gpr56 and Gpr97 during hematopoietic cell development and differentiation
Maglitto, A., Mariani, S. A., de Pater, E., Rodríguez‐Seoane, C., Vink, C. S., Piao, X., Lukke, M.-L., & Dzierzak, E. A. (2021) · Blood Advances · doi:10.1182/bloodadvances.2020003693 · Cited by 22
When 3D genome changes cause disease: the impact of structural variations in congenital disease and cancer
Weischenfeldt, J., & Ibrahim, D. M. (2023) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2023.102048 · Cited by 19
Cancer and meiotic gene expression: Two sides of the same coin?
Sou, I. F., Hamer, G., Tee, W., Vader, G., & McClurg, U. L. (2022) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/bs.ctdb.2022.06.002 · Cited by 22
The molecular understanding of super-enhancer dysregulation in cancer.
Yoshino, S., & Suzuki, H. I. (2022) · PubMed Central · doi:10.18999/nagjms.84.2.216 · Cited by 23
MECOM Deficiency: from Bone Marrow Failure to Impaired B-Cell Development
Voit, R. A., & Sankaran, V. G. (2023) · Journal of Clinical Immunology · doi:10.1007/s10875-023-01545-0 · Cited by 22
BRCA1 mutations attenuate super-enhancer function and chromatin looping in haploinsufficient human breast epithelial cells
Zhang, X., Wang, Y., Chiang, H.-C., Hsieh, Y.-P., Lu, C., Park, B. H., Jatoi, I., Jin, V. X., Hu, Y., & Li, R. (2019) · Breast Cancer Research · doi:10.1186/s13058-019-1132-1 · Cited by 22
Hematopoietic transcriptional mechanisms: From locus-specific to genome-wide vantage points
DeVilbiss, A., Sanalkumar, R., Johnson, K. D., Keleş, S., & Bresnick, E. H. (2014) · Experimental Hematology · doi:10.1016/j.exphem.2014.05.004 · Cited by 21
Finding cancer driver mutations in the era of big data research
Poulos, R., & Wong, J. W. H. (2018) · Biophysical Reviews · doi:10.1007/s12551-018-0415-6 · Cited by 20
All-trans retinoic acid enhances, and a pan-RAR antagonist counteracts, the stem cell promoting activity of EVI1 in acute myeloid leukemia
Nguyen, C. H., Bauer, K., Hackl, H., Schlerka, A., Koller, E., Hladik, A., Stoiber, D., Zuber, J., Staber, P., Hoelbl-Kovacic, A., et al. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-2172-2 · Cited by 18
Functions and Clinical Significance of Super-Enhancers in Bone-Related Diseases
Qu, J., Ouyang, Z., Wu, W., Li, G., Wang, J., Lu, Q., & Li, Z. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00534 · Cited by 21
LncRNA:DNA triplex-forming sites are positioned at specific areas of genome organization and are predictors for Topologically Associated Domains
Soibam, B., & Zhamangaraeva, A. (2021) · BMC Genomics · doi:10.1186/s12864-021-07727-7 · Cited by 20
EVI1 activates tumor-promoting transcriptional enhancers in pancreatic cancer
Kim, H.-R., Yim, J., Yoo, H.-B., Lee, S. E., Oh, S., Jung, S., Hwang, C., Shin, D., Kim, T. S., Yoo, K. H., et al. (2021) · NAR Cancer · doi:10.1093/narcan/zcab023 · Cited by 21
Super enhancers as master gene regulators in the pathogenesis of hematologic malignancies
Debek, S. M., & Juszczyński, P. (2022) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2022.188697 · Cited by 23

Authors: Gröschel, S., Sanders, M. A., Hoogenboezem, R., de Wit, E., Bouwman, B. A. M., Erpelinck, C., van der Velden, V. H. J., Havermans, M., Avellino, R., van Lom, K., Rombouts, E. J., van Duin, M., Döhner, K., Beverloo, H. B., Bradner, J. E., Döhner, H., Löwenberg, B., Valk, P. J. M., Bindels, E. M. J., de Laat, W., & Delwel, R.
Affiliations: Erasmus MC (NL)
University Medical Center Utrecht (NL)
University Hospital Ulm (DE)
Harvard University (US)
Corresponding author: Delwel, Ruud
ORCID: Gröschel, Stefan
Sanders, Mathijs A.
Hoogenboezem, Remco
Bouwman, Britta A.M.
Havermans, Marije
Avellino, Roberto
Döhner, Konstanze
Beverloo, H. Berna
Bradner, James E.
Döhner, Hartmut
Löwenberg, Bob
Valk, Peter J.M.
Bindels, Eric M.J.
Delwel, Ruud
Venue: Cell
Publisher: Elsevier BV
Published: 2014-04
Volume: 157
Issue: 2
Pages: 369-381
ISSN: 0092-8674 (ISSN-L)
DOI: 10.1016/j.cell.2014.02.019
OpenAlex: W1978902427
Cited by: 687
References: 51
Citations by year: 2026: 29 · 2025: 45 · 2024: 42 · 2023: 72 · 2022: 55 · 2021: 69 · 2020: 66 · 2019: 62 · 2018: 59 · 2017: 65 · 2016: 59 · 2015: 45 · 2014: 15
FWCI: 43.09
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/legal/tdmrep-license (tdm)
www.elsevier.com/open-access/userlicense/1.0/ (vor, 444 d)
Locations: Cell (publishedVersion)
PubMed (publishedVersion)
EUR Research Repository (Erasmus University Rotterdam) (publishedVersion)
KNAW research portal (Royal Academy of Art and Sciences (KNAW)) (publishedVersion)
EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
Data Archiving and Networked Services (DANS) (submittedVersion)
Funders: Association for International Cancer Research
Deutsche Forschungsgemeinschaft (GR 3955/1-1)
Lady Tata Memorial Trust
European Hematology Association
Center for Translational Molecular Medicine (GR03O-102)
Topics: Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
Keywords: EVI1, GATA2, acute myeloid leukemia, haploinsufficiency, BET inhibition, leukemia cell differentiation, leukemogenesis
MeSH terms: MDS1 and EVI1 Complex Locus Protein, Chromosomes, Human, Pair 3, DNA-Binding Proteins, Enhancer Elements, Genetic, Humans, Chromosome Inversion, Myelodysplastic Syndromes, Promoter Regions, Genetic, Proto-Oncogenes, Transcription Factors, Translocation, Genetic, Leukemia, Myeloid, Acute, Transcriptional Activation, Gene Expression Regulation, Neoplastic, Cell Line, Tumor, GATA2 Transcription Factor

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

A Single Oncogenic Enhancer Rearrangement Causes Concomitant EVI1 and GATA2 Deregulation in Leukemia

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks